Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Equity Ratio (2016 - 2018)

Historic Equity Ratio for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to 0.83.

  • Armata Pharmaceuticals' Equity Ratio rose 1699.47% to 0.83 in Q3 2018 from the same period last year, while for Sep 2018 it was 0.83, marking a year-over-year increase of 1699.47%. This contributed to the annual value of 0.69 for FY2017, which is 2959.15% up from last year.
  • As of Q3 2018, Armata Pharmaceuticals' Equity Ratio stood at 0.83, which was up 1699.47% from 0.99 recorded in Q2 2018.
  • Armata Pharmaceuticals' Equity Ratio's 5-year high stood at 28.37 during Q1 2018, with a 5-year trough of 0.91 in Q1 2014.
  • Its 5-year average for Equity Ratio is 1.84, with a median of 0.46 in 2017.
  • Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 1103.64% in 2017, then surged by 600278.8% in 2018.
  • Armata Pharmaceuticals' Equity Ratio (Quarter) stood at 0.12 in 2014, then skyrocketed by 236.13% to 0.4 in 2015, then skyrocketed by 32.67% to 0.54 in 2016, then rose by 29.59% to 0.69 in 2017, then rose by 19.34% to 0.83 in 2018.
  • Its Equity Ratio was 0.83 in Q3 2018, compared to 0.99 in Q2 2018 and 28.37 in Q1 2018.